Hyperprolactinemic disorders.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000503:physiopathology; D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000628:therapy; D007172:Erectile Dysfunction / Q000503:physiopathology; D005260:Female; D005687:Galactorrhea / Q000503:physiopathology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000000981:diagnostic imaging / Q000502:physiology; D007031:Hypothalamus / Q000502:physiology; D007247:Infertility, Female / Q000503:physiopathology; D008297:Male; D010911:Pituitary Neoplasms / Q000378:metabolism; D011247:Pregnancy; D011388:Prolactin / Q000097:blood* / Q000378:metabolism; D011389:Prolactin Release-Inhibiting Factors / Q000502:physiology; D051381:Rats; D011956:Receptors, Cell Surface / Q000502:physiology; D011981:Receptors, Prolactin; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology; D014057:Tomography, X-Ray Computed
D011956:Receptors, Cell Surface; D011981:Receptors, Prolactin; D001971:Bromocriptine; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D011389:Prolactin Release-Inhibiting Factors